DUBLIN, Ohio, Nov. 11, 2024 /PRNewswire/ -- Cardinal health (NYSE: CAH ) announced today that it has entered into definitive agreements to acquire two companies that accelerate Cardinal Health's ...
At Greenwich Hospital, Oh will continue to develop integrated oncology care teams and expand the impact of multidisciplinary ...
RANO 2.0 incorporates an integrated quantitative assessment of both enhancing ... Wen, MD, Director of the Center for Neuro-Oncology at Dana-Farber Cancer Institute. Details for the RANO 2.0 ...
Dr. William Oh is the new medical director of Smilow Cancer Hospital at Greenwich Hospital. Photo courtesy of Yale Cancer ...
Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course ...
DNA synthesis platform developer joins de novo designer in latest of three partnerships recently launched or advanced.
Ravi B Parikh, MD, MPP discusses the current and future use of artificial intelligence (AI) in the greater US health care ...
Planegg/Martinsried, November 11, 2024.Medigene AG (Medigene or the “Company”, FSE: MDG1, Prime Standard), an oncology platform company focused ...
Fulgent Genetics is transitioning toward becoming a fully integrated precision medicine company. This strategic shift focuses ...
Twist Bioscience focuses on synthetic DNA manufacturing, leveraging its proprietary silicon-based platform. Find out why I'm ...
CytoDyn gets US FDA nod to begin phase II oncology trial of leronlimab in patients with r/r microsatellite stable colorectal cancer: Vancouver, Washington Wednesday, November 6, 2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback